Publications

Pharm Res. 2004 Sep .

Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo.

Rudolph C, Schillinger U, Ortiz A, Tabatt K, Plank C, Müller RH, Rosenecker J

To optimize gene delivery of SLN-based gene vectors by incorporation of a dimeric HIV-1 TAT peptide (TAT2) into SLN gene vectors.

PMID: 15497694 [PubMed - in process]
Back